Vital Therapies once again lowers the bar on its initial public offering, pricing the flotation at $12 per share.
Vital Therapies priced its initial public offering at $12 per share, once again lowering the bar for its 1st public flotation after scuttling its 1st try at a U.S. IPO.
Vital Therapies, which is developing a bio-artificial liver, last October set the IPO's price range at $16-$18. But the San Diego-based company but shelved the offering until March, when it set the range at $13-$15 per share.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lbzhte
Cap comentari:
Publica un comentari a l'entrada